Associate in Pediatrics, Genetics
Boston Children's Hospital
Harvard Medical School
Ingrid A. Holm, MD, MPH is Associate Professor of Pediatrics at Harvard Medical School and faculty of the Division of Genetics and Genomics at Boston Children’s Hospital (BCH). Dr. Holm’s research interest is in the Ethical, Legal, and Social Implications of returning genomic information to participants, families, and health care providers. She is co-investigator on the Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) U19 “Genomic Sequencing and Newborn Screening Disorders” (BabySeq), which explores the medical, behavioral, and economic impacts of integrating genomic sequencing into newborn care. She is co-investigator in the Electronic Medical Records and Genomics (eMERGE) III Network where she co-chairs the Return of Results-ELSI Work Group, and she is the PI of an NHGRI-funded R01 to study the impact of return of genetic information on eMERGE participants to their providers. Dr. Holm is also funded by PCORI (Patient Centered Outcomes Research Institute) to develop self-phenotyping methods for patients with undiagnosed diseases. She is Associate Director of Robert’s Program for Sudden Unexpected Death in Pediatrics (SUDP) Program at BCH and leads the genomic sequencing studies. Dr. Holm is a member of the BCH IRB and is a member of the NIH All of Us Research Program IRB.
Monday, November 18
10:15 AM – 11:30 AM